BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17266036)

  • 1. Involvement of aminopeptidase N in enhanced chemosensitivity to paclitaxel in ovarian carcinoma in vitro and in vivo.
    Yamashita M; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
    Int J Cancer; 2007 May; 120(10):2243-50. PubMed ID: 17266036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells.
    Terauchi M; Kajiyama H; Shibata K; Ino K; Nawa A; Mizutani S; Kikkawa F
    BMC Cancer; 2007 Jul; 7():140. PubMed ID: 17655775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
    Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX
    Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.
    Gao JJ; Gao ZH; Zhao CR; Yuan Y; Cui SX; Zhang XF; Cheng YN; Xu WF; Tang W; Qu XJ
    Invest New Drugs; 2011 Aug; 29(4):574-82. PubMed ID: 20111888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13).
    Cui SX; Zhang HL; Xu WF; Qu XJ
    Eur J Pharmacol; 2014 Jul; 734():50-9. PubMed ID: 24726845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIP-13F, a novel aminopeptidase N (APN/CD13) inhibitor, inhibits Lewis lung carcinoma growth and metastasis in mice.
    Pei KL; Yuan Y; Qin SH; Wang Y; Zhou L; Zhang HL; Qu XJ; Cui SX
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):1029-38. PubMed ID: 22186885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
    Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
    Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
    Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
    BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary detection of the anti‑tumour activity of indoline‑2,3‑dione derivative DH‑12a targeting aminopeptidase N.
    Cui DX; Wang XJ; Zhang XR; Zhao TK; Guo XX; Liu SM; Wang B; Ma WQ; Gao ZQ
    Mol Med Rep; 2014 Nov; 10(5):2681-8. PubMed ID: 25216231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition.
    Sun ZP; Zhang J; Shi LH; Zhang XR; Duan Y; Xu WF; Dai G; Wang XJ
    Biomed Pharmacother; 2015 Dec; 76():65-72. PubMed ID: 26653552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N/CD13 expression.
    Kato M; Azuma H; Akaike M; Iuchi T; Aihara K; Ikeda Y; Fujimura M; Yoshida T; Yamaguchi H; Hashizume S; Matsumoto T
    Atherosclerosis; 2005 Nov; 183(1):49-55. PubMed ID: 16216591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression, regulation and functional activities of aminopeptidase N (EC 3.4.11.2; APN; CD13) on murine macrophage J774 cell line.
    Gabrilovac J; Cupić B; Zivković E; Horvat L; Majhen D
    Immunobiology; 2011; 216(1-2):132-44. PubMed ID: 20638153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
    Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
    Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible contribution of aminopeptidase N (APN/CD13) to migration and invasion of human osteosarcoma cell lines.
    Liang W; Gao B; Xu G; Weng D; Xie M; Qian Y
    Int J Oncol; 2014 Dec; 45(6):2475-85. PubMed ID: 25340499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells.
    Kajiyama H; Shibata K; Ino K; Mizutani S; Nawa A; Kikkawa F
    Cancer Sci; 2010 Feb; 101(2):347-54. PubMed ID: 19917055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
    Ma C; Jin K; Cao J; Zhang L; Li X; Xu W
    Bioorg Med Chem; 2013 Apr; 21(7):1621-7. PubMed ID: 23453219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MT95-4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model.
    Akita S; Hattori N; Masuda T; Horimasu Y; Nakashima T; Iwamoto H; Fujitaka K; Miyake M; Kohno N
    Cancer Sci; 2015 Jul; 106(7):921-8. PubMed ID: 25950387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.
    Zhang X; Zhang L; Zhang J; Feng J; Yuan Y; Fang H; Xu W
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):545-51. PubMed ID: 22380779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
    Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
    Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of APN/CD13 on bestatin enhancing all-trans-retinoic acid-inducing differentiation in NB4 cells].
    Qian XJ; Lin MF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1125-8. PubMed ID: 22040956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.